Eastern and South-Eastern Asia vs Russian Federation: Proportion of the target population who received a 3rd dose of
Eastern and South-Eastern Asia
33.0%
in 2024
Russian Federation
94.0%
in 2024
Eastern and South-Eastern Asia rank
36th
Russian Federation rank
36th
Proportion of the target population who received a 3rd dose of over time
- Eastern and South-Eastern Asia
- Russian Federation
How they compare
Russian Federation currently reports 94.0% against 33.0% in Eastern and South-Eastern Asia, a difference of 61.0%.
That makes Russian Federation's figure about 2.8 times Eastern and South-Eastern Asia's.
Across all 9 years both countries report, Russian Federation has been ahead every year.
Eastern and South-Eastern Asia ranks 36th and Russian Federation ranks 36th of 37 groups.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11.8% | 67.8% | 56.0% | Russian Federation |
| 2020s | 22.2% | 91.0% | 68.8% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Eastern and South-Eastern Asia or Russian Federation?
- Russian Federation, at 94.0% against 33.0% in Eastern and South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Eastern and South-Eastern Asia and Russian Federation?
- 61.0%, with Russian Federation ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and Russian Federation?
- 9 years are reported by both, from 2016 to 2024.
- How do Eastern and South-Eastern Asia and Russian Federation rank globally for proportion of the target population who received a 3rd dose of?
- Eastern and South-Eastern Asia ranks 36th and Russian Federation ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.